Clinical Trial Update: Effects of Salmeterol on Walking Capacity in Patients With COPD [Phase 4]

View source ↗

Summary

This update reports a completed Phase 4 trial evaluating the effect of salmeterol on walking capacity in patients with chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Salmeterol (salmeterol)

Snippet

Sponsor: Laval University | Conditions: Chronic Obstructive Pulmonary Disease | Phase 4 | Status: COMPLETED